125 related articles for article (PubMed ID: 19125739)
1. Development of an in vitro Bowen's disease model using a three-dimensional culture system.
Lee DY; Yang JM
J Cutan Pathol; 2009 Jan; 36(1):82-3. PubMed ID: 19125739
[No Abstract] [Full Text] [Related]
2. Partial spontaneous regression of Bowen's disease.
Murata Y; Kumano K; Sashikata T
Arch Dermatol; 1996 Apr; 132(4):429-32. PubMed ID: 8629847
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
[No Abstract] [Full Text] [Related]
4. p63 constitutes a useful histochemical marker for differentiation of pagetoid Bowen's disease from extramammary Paget's disease.
Memezawa A; Okuyama R; Tagami H; Aiba S
Acta Derm Venereol; 2008; 88(6):619-20. PubMed ID: 19002351
[No Abstract] [Full Text] [Related]
5. Spontaneous complete regression of multiple Bowen's disease in the web-spaces of the feet.
Masuda T; Hara H; Shimojima H; Suzuki H; Tanaka K
Int J Dermatol; 2006 Jun; 45(6):783-5. PubMed ID: 16796655
[No Abstract] [Full Text] [Related]
6. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
8. Bowen's disease with invasive adnexal carcinoma: the pluripotential nature of Bowen's disease cells.
Kamiya H; Kitajima Y; Ban M
J Dermatol; 2006 Dec; 33(12):858-64. PubMed ID: 17169090
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of cytokeratin 7 expression in pagetoid Bowen's disease.
Misago N; Toda S; Narisawa Y
J Cutan Pathol; 2012 Jul; 39(7):724-6. PubMed ID: 22390404
[No Abstract] [Full Text] [Related]
10. Overexpression of transforming growth factor-beta3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Int J Dermatol; 2001 Apr; 40(4):262-7. PubMed ID: 11454082
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease.
Böer-Auer A; Jones M; Lyasnichaya OV
J Cutan Pathol; 2012 Feb; 39(2):225-33. PubMed ID: 22236073
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 protein is expressed in Bowen's disease.
Sim CS; Slater SD; McKee PH
Am J Dermatopathol; 1992 Jun; 14(3):195-9. PubMed ID: 1510215
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms.
Lining X; Uchi H; Hayashida S; Tsuji G; Kido M; Nakahara T; Takeuchi S; Takahara M; Moroi Y; Furue M
J Dermatol Sci; 2009 Nov; 56(2):135-6. PubMed ID: 19660915
[No Abstract] [Full Text] [Related]
14. Warty and clear cell Bowen's disease.
Hernández-Pérez E; Figueroa DE
Int J Dermatol; 2005 Jul; 44(7):586-7. PubMed ID: 15985030
[No Abstract] [Full Text] [Related]
15. [Pigmented Bowen's disease].
Cicale L; Dalle S; Thomas L
Ann Dermatol Venereol; 2008 Apr; 135(4):334-6. PubMed ID: 18420088
[No Abstract] [Full Text] [Related]
16. Bowen's disease clinically simulating an onychomatricoma.
Baran R; Perrin C
J Am Acad Dermatol; 2002 Dec; 47(6):947-9. PubMed ID: 12451385
[TBL] [Abstract][Full Text] [Related]
17. STAT3-dependent VEGF production from keratinocytes abrogates dendritic cell activation and migration by arsenic: a plausible regional mechanism of immunosuppression in arsenical cancers.
Hong CH; Lee CH; Chen GS; Chang KL; Yu HS
Chem Biol Interact; 2015 Feb; 227():96-103. PubMed ID: 25559853
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial biogenesis drives tumor cell proliferation.
Martinez-Outschoorn UE; Pavlides S; Sotgia F; Lisanti MP
Am J Pathol; 2011 May; 178(5):1949-52. PubMed ID: 21514412
[TBL] [Abstract][Full Text] [Related]
19. A challenging toenail melanonychia.
Russo T; Piccolo V; Panarese I; Alfano R; Argenziano G
J Dtsch Dermatol Ges; 2019 Jan; 17(1):85-86. PubMed ID: 30592552
[No Abstract] [Full Text] [Related]
20. The specific dermoscopic criteria of Bowen's disease.
Zalaudek I; Di Stefani A; Argenziano G
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):361-2. PubMed ID: 16503917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
